|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Endoscopic ultrasound guided radiofrequency ablation,for pancreatic cystic neoplasms and neuroendocrine tumors显示文摘AIM: To outline the feasibility, safety, adverse events and early results of endoscopic ultrasound(EUS)-radiofrequency ablation(RFA) in pancreatic neoplasms using a novel probe. METHODS: This is a multi-center, pilot safety feasibility study. The intervention described was radiofrequency ablation(RF) which was applied with an innovative monopolar RF probe(1.2 mm Habib EUS-RFA catheter) placed through a 19 or 22 gauge fine needle aspiration(FNA) needle once FNA was performed in patients with a tumor in the head of the pancreas. The HabibTM EUSRFA is a 1 Fr wire(0.33 mm, 0.013') with a working length of 190 cm, which can be inserted through the biopsy channel of an echoendoscope. RF power is applied to the electrode at the end of the wire to coagulate tissue in the liver and pancreas.RESULTS: Eight patients [median age of 65(range 27-82) years; 7 female and 1 male] were recruited in a prospective multicenter trial. Six had a pancreatic cysticneoplasm(four a mucinous cyst, one had intraductal papillary mucinous neoplasm and one a microcystic adenoma) and two had a neuroendocrine tumors(NET) in the head of pancreas. The mean size of the cystic neoplasm and NET were 36.5 mm(SD ± 17.9 mm) and 27.5 mm(SD ± 17.7 mm) respectively. The EUSRFA was successfully completed in all cases. Among the 6 patients with a cystic neoplasm, post procedure imaging in 3-6 mo showed complete resolution of the cysts in 2 cases, whilst in three more there was a 48.4% reduction [mean pre RF 38.8 mm(SD ± 21.7 mm) vs mean post RF 20 mm(SD ± 17.1 mm)] in size. In regards to the NET patients, there was a change in vascularity and central necrosis after EUS-RFA. No major complications were observed within 48 h of the procedure. Two patients had mild abdominal pain that resolved within 3 d. CONCLUSION: EUS-RFA of pancreatic neoplasms with a novel monopolar RF probe was well tolerated in all cases. Our preliminary data suggest that the procedure is straightforward and safe. The response ranged from complete resolution to a 50% reduction in size. | Madhava Pai Nagy Habib Hakan Senturk Sundeep Lakhtakia Nageshwar Reddy Vito R Cicinnati Iyad Kaba Susanne Beckebaum Panagiotis Drymousis Michel Kahaleh William Brugge | 2015 | World Journal of Gastrointestinal Surgery2015，7，4： | 23 |
| 2 | Donation after cardio-circulatory death liver transplantation显示文摘The renewed interest in donation after cardio-circulatory death (DCD) started in the 1990s following the limited success of the transplant community to expand the donation after brain-death (DBD) organ supply and following the request of potential DCD families. Since then, DCD organ procurement and transplantation activities have rapidly expanded, particularly for nonvital organs, like kidneys. In liver transplantation (LT), DCD donors are a valuable organ source that helps to decrease the mortality rate on the waiting lists and to increase the availability of organs for transplantation despite a higher risk of early graft dysfunction, more frequent vascular and ischemia-type biliary lesions, higher rates of re-listing and re-transplantation and lower graft survival, which are obviously due to theinevitable warm ischemia occurring during the declaration of death and organ retrieval process. Experimental strategies intervening in both donors and recipients at different phases of the transplantation process have focused on the attenuation of ischemia-reperfusion injury and already gained encouraging results, and some of them have found their way from pre-clinical success into clinical reality. The future of DCD-LT is promising. Concerted efforts should concentrate on the identification of suitable donors (probably Maastricht category Ⅲ DCD donors), better donor and recipient matching (high risk donors to low risk recipients), use of advanced organ preservation techniques (oxygenated hypothermic machine perfusion, normothermic machine perfusion, venous systemic oxygen persufflation), and pharmacological modulation (probably a multi-factorial biologic modulation strategy) so that DCD liver allografts could be safely utilized and attain equivalent results as DBD-LT. | Hieu Le Dinh Arnaud de Roover Abdour Kaba Séverine Lauwick Jean Joris Jean Delwaide Pierre Honoré Michel Meurisse Olivier Detry | 2012 | World Journal of Gastroenterology2012，18，33： | 6 |
| 3 | Lectin histochemistry of human gliomas显示文摘 | X. -C. Wang N. Kochi E. Tani K. Kaba T. Matsumoto H. Shindo | 1989 | Acta Neuropathologica1989，，2： | 2 |
| 4 | They Listen to Me,But They Don't Ac! on h:Contra- dictory Consciousness and Student Participation in Decision-Making 显示文摘 | Kaba M | 2001 | High School Jom''nal2001，84，2： | 1 |
| 5 | Direct electrochemical oxidation of organics for wastewatertreatment 显示文摘 | Murphy O J Hitchens D G Kaba L | 1992 | Water Research1992，26，4： | 1 |
| 6 | Dickkopf-1 levels in Turkish patients with bladder cancer and its association with clinicopatho- logical features 显示文摘 | Kaba M Pifincci N Benli E | 2014 | Asian Pac J Cancer Prev2014，15，1： | 1 |
| 7 | Fusion to green fluorescent protein improves expression levels of Theileria parva sporozoite surface antigen p67 in insect cells显示文摘 | Kaba SA Neve V Musoke A J | | 0，，： | 1 |
| 8 | Hypertension: epidemiology and metabolic abnormalities in Foutah- Djallon in Guinea显示文摘 | Balde MD Balde NM Kaba ME | 2006 | Mali Med2006，21，3： | 1 |
| 9 | Comparison of connexin expression patterns in the developing mouse heart and human foetal heart显示文摘 | Coppen SR Kaba RA Halliday D | 2003 | Mol Cell Biochem2003，242，12： | 1 |
| 10 | Angiopoietinlike 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation显示文摘 | Cheng Cheng Zhang Megan Kaba Satoru lizuka | 2008 | Blood2008，111，： | 1 |
| 11 | Comparison of connexin 43, 40 and 45 expression patterns in the developing human and mouse hearts显示文摘 | Kaba RA Coppen SR Dupont E | 2001 | Cell Commun Adhes2001，8，46： | 1 |
| 12 | Donor age as a risk factor in donation after circulatory death liver transplantation in a controlled withdrawal protocol programme显示文摘 | O. Detry A. Deroover N. Meurisse M. F. Hans J. Delwaide S. Lauwick A. Kaba J. Joris M. Meurisse P. Honoré | 2014 | Br J Surg2014，，7： | 1 |
| 13 | Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy显示文摘 | Kaba A Laurent SR Detroz BJ | 2007 | Anesthesiology2007，106，1： | 1 |
| 14 | Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction显示文摘 | Kaba NK Francis CW Moss AJ | 2004 | J Thromb Haemost2004，5，： | 1 |
| 15 | Maturation time and some seed composition characters affecting nutritive value in soybean varieties 显示文摘 | Kriboruchco D Kaba H Sambucetti M E | 1979 | Cereal Chemistry1979，56，4： | 1 |
| 16 | Intravenous lidocaineinfusion facilitates acute rehabilitation after laparoscopic colec- tomy显示文摘 | Kaba A Laurent S R Detroz B J | 2007 | Anesthesiology2007，106，1： | 1 |
| 17 | Intravenous lidocaine infusion reduces bispectral index-guided requirements of propofol only during surgical stimulation显示文摘 | Hans GA Lauwick SM Kaba A | | 0，，04： | 1 |
| 18 | A note on the organization and expression of β-defensin genes in Polish goats显示文摘 | E. Bagnicka B. Prusak E. Ko?ciuczuk J. Jarczak J. Kaba N. Strza?kowska A. Jó?wik M. Czopowicz J. Krzy?ewski L. Zwierzchowski | 2013 | Journal of Applied Genetics2013，，1： | 1 |
| 19 | PFGE and AFLP genotyping of Staphylococcus aureus subsp . anaerobius isolated from goats with Morel’s disease显示文摘 | O. Szalu?-Jordanow D. Chrobak M. Pyrgiel A. Lutyńska J. Kaba M. Czopowicz L. Witkowski M. Kizerwetter-?wida M. Binek T. Frymus | 2013 | Archives of Microbiology2013，，1： | 1 |
| 20 | Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response : A prospective, randomized, clinical trial 显示文摘 | Kucuk T Kozinoghi H Kaba A | 2008 | J Assist Reprod Genet2008，25，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员